Actively Recruiting
FAPI-PET for Tumor Detection
Led by University Hospital, Essen · Updated on 2023-11-29
500
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.
CONDITIONS
Official Title
FAPI-PET for Tumor Detection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- FAPI-PET scheduled for staging or restaging as part of clinical routine for proven or suspected malignancy
- Age 18 years or older
You will not qualify if you...
- Unable to give consent for the study
- Unable to lie flat or tolerate FAPI PET imaging
- Unwillingness or inability to comply with study and follow-up procedures
- Condition making participation critical in investigators' discretion
- Pregnant, lactating, or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Nuclear medicine, University hospital Essen
Essen, North Rhine-Westphalia, Germany, 45147
Actively Recruiting
Research Team
W
Wolfgang Fendler, MD
CONTACT
L
Lukas Kessler, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here